Our finding that pharmacologic inhibition of the mTOR pathway decreased the rate of formation of TNTs between ovarian cancer cells may provide a rationale for a new approach to preventing development of chemotherapy resistance via a TNT-mediated mechanism. The gene discussed is MTOR; the disease is ovarian carcinoma.